| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e36238d9af195acab1d38b3df8621a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d731b813db6adf8f80880854382e3486 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate |
2020-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_876fbb6aeac21ba943577a02aa013c33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e16d764b7047900a2c6bccdfe96a9be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caf666fbd787d5042f3efae78f59516d |
| publicationDate |
2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021107385-A |
| titleOfInvention |
Pharmaceutical composition containing menstrual blood-derived stem cell culture supernatant |
| abstract |
【Theme】 The purpose is to provide a new ART (Assisted Reproductive Technology) that can effectively treat endometrial insufficiency and infertility. SOLUTION: A pharmaceutical composition for treating endometrial failure and / or infertility, which comprises a culture supernatant of stem cells derived from menstrual blood. The menstrual blood is preferably autologous menstrual blood of a patient in need of treatment, and the culture supernatant is administered intrauterinely in the patient who desires treatment. [Selection diagram] none |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115094025-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115094025-B |
| priorityDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |